What These 2 Neurodegenerative Studies Could Mean for the Future of Axovant
Axovant Sciences has produced results from two separate studies related to neurodegenerative diseases, and its shares had a sharp gain to start off the week.
All Work
Chris Lange
10 Reasons Merrill Lynch Is Now Bullish on Apple
Merrill Lynch has come out in favor of Apple, and the analyst sees a very bullish future for the company for a number of reasons.
Broadcom, Dollar General, Oracle and More Major Earnings Coming This Week
24/7 Wall St. has put together a preview of Adobe, Dollar General, Oracle and other earnings reports that are coming out this week.
Friday’s Biggest Winners and Losers in the S&P 500
Friday was a down day for the broad U.S. markets. The S&P 500 and Dow Jones really pulled back from their highs this week, which would make this the first down week in a…
What Is Holding Marvell Technology Back in 2019
Marvell Technology shares pulled back on Friday after it reported fiscal fourth-quarter financial results late on Thursday.
Can Tonix Regain Its Former Glory With New Neurodegenerative Dysfunction Drug?
Tonix Pharma shares spiked on Friday after the firm announced that it received a patent from the European Patent Office for its “Method for Treating Neurodegenerative Dysfunction.”
Can Costco Keep Up After Q1?
Costco shares rose after it released mixed fiscal first-quarter financial results after the markets closed on Thursday.
Thursday’s Biggest Winners and Losers in the S&P 500
Thursday was a down day for the broad U.S. markets. The S&P 500 and Dow Jones are continuing to pull back from their highs this year, which would make this the first down week…
Bio-Path Shares on the Warpath
Bio-Path shares are on a rampage, with its second day of more than doubling. Shares actually were halted at multiple points during the day for volatility spikes. This is all coming after the firm…
Why One Analyst Sees Over 20% Upside at Netflix
Some would argue that it might be too early to start making guesses about where Netflix’s subscriber numbers end up. However, one analyst has taken on this to task and sees more than 20%…
What to Expect When Costco Reports After the Close
Costco is scheduled to release its fiscal second-quarter financial results after the markets close on Thursday, and analysts are looking for solid year-over-year growth.
Guidewire Software Pulls Ahead With Earnings
Guidewire Software shares rallied after it reported better-than-expected quarterly results late Wednesday.
Will Barnes & Noble Ever Get Earnings Right?
After Barnes & Noble reported disappointing fiscal third-quarter financial results early Thursday, its share price tumbled.
Why Kroger Is Getting Dragged for Q4 Results
Kroger shares tumbled after it released its fiscal fourth-quarter financial results before the markets opened on Thursday.
Wednesday’s Biggest Winners and Losers in the S&P 500
Wednesday was a down day for the broad U.S. markets. The S&P 500 and Dow Jones are continuing to pull back from their highs this year. Crude oil dipped as well in the session.…
Why Bio-Path Shares Nearly Tripled
Bio-Path shares made an incredible run on Wednesday after the company announced interim results from its mid-stage leukemia trial.
What to Expect When Kroger Reports Thursday Morning
Wall Street expects Kroger to offer up muted fiscal fourth-quarter financial results before the markets open on Thursday.
What’s Driving Ambarella Forward in 2019
Ambarella shares soared early Wednesday after reported its most recent quarterly results late on Tuesday.
Is Dollar Tree a Bargain After Q4 Results?
Dollar Tree reported nearly in-line quarterly results before the markets opened on Wednesday but disappointing earnings guidance. Yet shares were up early on.
Tuesday’s Biggest Winners and Losers in the S&P 500
Tuesday was a relatively flat day for the broad U.S. markets. The S&P 500 and Dow Jones could not make up their minds in this session bouncing from positive to negative and back multiple…